LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Operating Expenses | 7,340 | 4,420 | 4,790 | 3,280 | 3,140 |
| Operating Income | -7,340 | -4,420 | -4,790 | -3,280 | -3,140 |
| Interest Expense | 0 | 0 | 1 | 2 | 3 |
| Other Income | 800 | 710 | 571 | 292 | 273 |
| Pre-tax Income | -6,540 | -3,710 | -4,220 | -2,990 | -2,870 |
| Net Income Continuous | -6,549 | -3,706 | -4,222 | -2,994 | -2,877 |
| Net Income | $-6,549 | $-3,706 | $-4,222 | $-2,994 | $-2,877 |
| EPS Basic Total Ops | -500,000.00 | -325,000.00 | -375,000.00 | -300,000.00 | -325,000.00 |
| EPS Basic Continuous Ops | -500,000.00 | -325,000.00 | -375,000.00 | -300,000.00 | -325,000.00 |
| EPS Diluted Total Ops | -500,000.00 | -325,000.00 | -375,000.00 | -300,000.00 | -325,000.00 |
| EPS Diluted Continuous Ops | -500,000.00 | -325,000.00 | -375,000.00 | -300,000.00 | -325,000.00 |
| EBITDA(a) | $-7,270 | $-4,320 | $-4,700 | $-3,180 | $-3,050 |